Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Company Financials: Orthopaedic and Spine

ORTHOWORLD estimates place 2Q11 market growth at 5% over 2Q10 as shown in Exhibit 1, which displays 2Q orthopaedic sales growth by product segment for select companies. Performance highlights follow.


Exhibit 1: Orthopaedic Sales1 Increases by Product Segment: 2Q11 vs. 2Q10 

Notes to Exhibit 1

1 Orthopaedic products only; constant currency, pro forma growth
2 Includes biologics
3 For the quarter ended 5/31/11; trauma includes stimulators; spine includes stimulators and orthobiologics.
4 For the quarter ended 7/29/11
5 Spine
6 For the quarter ended 6/30/11
7 Extremities: extremities + fixation combined; Endoscopy: endoscopic + communications, most of which is orthopaedic; Spine: neuro + spine. Total growth excludes Patient handling.
8 ORTHOWORLD estimates
9 For the quarter ended 6/30/11
10 Excludes "Other" (Aerospace)